ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Elicio Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.55−0.01 (-0.64%)
Close on Oct 19, 2026
- Market cap
- $29.83M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Elicio Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Dec 31, 2025 | Oct 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2025 | Sep 17, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 9, 2025 | Apr 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2025 | Jan 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2025 | Jan 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 22, 2025 | Jan 22, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 12, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2024 | Dec 3, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 21, 2024 | Nov 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |